Rating History for Allena Pharmaceuticals (ALNA) by B.Riley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/21/2022 | Mayank Mamtani | Downgrade | Neutral (Buy) |
0.50 (3.00) |
0.48 (0.08) |
-83.33% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/21/2022 | Mayank Mamtani | Downgrade | Neutral (Buy) |
0.50 (3.00) |
0.48 (0.08) |
-83.33% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||